Syrris, a leading chemistry automation product innovator, is delighted to announce that it has signed an exclusive worldwide agreement with Prosonix, a world leader in patented sonocrystallization technology. By combining Prosonix's ultrasound technology with Syrris's Atlas jacketed reactor platform, the Atlas SonoLab SL10 sonocrystalizer enables the reproducible control of crystallizations and allows selectivity of parameters such as particle size, shape, crystallinity and polymorph.

Mike Hawes, CEO of Syrris commented, "This is excellent news for Syrris' customers and therefore Syrris. The Atlas SonoLab SL10 system offers unrivalled crystallization control, enabling narrower particle size distribution, higher purity samples and greater polymorph selectivity than traditional techniques."

The Atlas SonoLab System is a high-performance, automated ultrasound system for sonocrystallization and sonomilling. With advanced control of nucleation and growth rate, the Atlas SonoLab System is ideal for particle engineering. Furthermore, utilising the new SonoLab equipment in conjunction with the Atlas platform provides a basis for quality ultrasonic experiments and a seamless transition from laboratory to pilot plant at scales ranging from 100 ml to 100 L.

For further information on the Atlas SonoLab System as well as the complete range of Atlas automated synthesis products, including systems for applications such as reaction calorimetry, pH monitoring and control, volumetric dosing, and gravimetric dosing, please visit www.syrris.com.